Dergiler / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 5

Clinical features and immunoglobulin replacement therapy outcomes of adults with common variable immunodeficiency: a single centre experience

Sayfa
2427–2436
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The later effect supports the immunomodulatory feature of this therapy.Key words: Common variable immunodeficiency, intravenous immunoglobulins, diarrhoea

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Common variable immunodeficiency (CVID) characterized by defective immunoglobulin production is the most prevalent form of symptomatic primary immunodeficiency (PID) in adults.
📊
Temel Bulgular & Veri:Materials and methods: This study included 26 adult patients receiving IRT.
💡
Sonuç & Katkı:The later effect supports the immunomodulatory feature of this therapy.Key words: Common variable immunodeficiency, intravenous immunoglobulins, diarrhoea
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Common variable immunodeficiency (CVID) characterized by defective immunoglobulin production is the most prevalent form of symptomatic primary immunodeficiency (PID) in adults. We aimed to reveal the clinical features of adults with CVID and to evaluate the effects of immunoglobulin replacement treatment (IRT) on hemato-immunological findings. Materials and methods: This study included 26 adult patients receiving IRT. Two measurements of complete blood counts and major immunoglobulin levels obtained at the beginning-end of follow up period were used for comparisons. Lymphocyte subsets and B-cell subgroups were measured only at the time of presentation. Results: The most common complications were related to respiratory and digestive systems and organomegaly. Chronic diarrhoea and low body weight were positively correlated with the percentage of CD8+ T cells (p = 0.019 and p = 0.003, respectively) but negatively correlated with the CD4/CD8 ratio and the percentage of CD19+ B cells (p = 0.019 and p = 0.005 for both parameters, respectively). At the end of period, the distribution of haematological parameters significantly improved, and immunoglobulin M (IgM) level increased to detectable levels (p = 0.035). Conclusions: There are apparent relationships among chronic diarrhoea and low body weight, and deterioration of T and B cell immunity in adults with CVID. IRT improves the whole blood parameters and stimulates immunoglobulin M (IgM) production. The later effect supports the immunomodulatory feature of this therapy.Key words: Common variable immunodeficiency, intravenous immunoglobulins, diarrhoea

🔖

Bu Makaleye Atıf Yap

ERDOĞAN, T., MUŞABAK, U. (2022). Clinical features and immunoglobulin replacement therapy outcomes of adults with common variable immunodeficiency: a single centre experience. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 5, 2427–2436. https://ajindex.com/articles/609553

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Abbott JK, Gelfand EW. Common variable immunodeficiency: diagnosis, management, and treatment. Immunology and Allergy Clinics of North America 2015; 35 (4): 637-658. doi: 10.1016/j.iac.2015.07.009
  2. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (PanAmerican Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clinical ımmunology 1999; 93 (3): 190-197. doi: 10.1006/clim.1999.4799
  3. Hooper AJ. The history and evolution of immunoglobulin products and their clinical indications. The Journal of Inherited Immune Disorders (LmyphoSign Journal) 2015; 2 (4): 181- 194. doi.org/10.14785/lpsn-2014-0025
  4. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin. The New England Journal of Medicine 2001; 345 (10): 747-755. doi: 10.1056/NEJMra993360
  5. Chaigne B, Mouthon L. Mechanisms of action of intravenous immunoglobulin. Transfusion and Apheresis Science 2016; 56 (1): 45-49. doi: 10.1016/j.transci.2016.12.017
  6. Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK et al. Update on the use of immunoglobulin in human disease: A review of evidence. The Journal of Allergy and Clinical Immunology 2017; 139 (3S): 1-46. doi: 10.1016/j.jaci.2016.09.023
  7. Maple-Brown LJ, Lawton PD, Hughes JT, Sharma SK, Jones GR et al. Study protocol-accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR study. BMC Public Health 2010; 10: 80. doi: 10.1186/1471-2458-10- 80
  8. Cunningham-Rundles C. How I treat common variable immune deficiency. Blood 2010; 116 (1): 7-15. doi: 10.1182/blood2010-01-254417
  9. Oksenhendler E, Gerard L, Fieschi C, Malphettes M, Mouillot G et al. Infections in 252 patients with common variable immunodeficiency. Clinical Infectious Diseases 2008; 46 (10): 1547-1554. doi: 10.1086/587669
  10. Malphettes M, Gérard L, Carmagnat M, Mouillot G, Vince N et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clinical Infectious Diseases 2009; 49 (9): 1329-1338. doi: 10.1086/606059
  11. Aghamohammadi A, Abolhassani H, Moazzami K, Parvaneh N, Rezaei N. Correlation between common variable immunodeficiency clinical phenotypes and parental consanguinity in children and adults. Journal of Investigational Allergology and Clinical Immunology 2010; 20 (5): 372-379. PMID: 20945602
  12. Ardeniz O, Başoğlu OK, Gunşar F, Unsel M